Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Karn

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|December 18, 2012
Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypesLars C Hanker, Achim Rody, Uwe Holtrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast CancerMaurizio Callari, Vera Cappelletti, Francesca D'Aiuto, et al.
Science Advances|September 16, 2020
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosisNandini Verma, Yaron Vinik, Ashish Saroha, et al.
Molecular Oncology|May 3, 2014
OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancerNicole Sänger, Eugen Ruckhäberle, Giampaolo Bianchini, et al.
Breast Cancer Research : BCR|March 11, 2009
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancersAchim Rody, Uwe Holtrich, Laos Pusztai, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2013
Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancerEugen Ruckhäberle, Thomas Karn, Carsten Denkert, et al.
Breast Care (Basel, Switzerland)|May 24, 2012
Breast Cancer Proteomics - Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag TechnologyEugen Ruckhäberle, Thomas Karn, Lars Hanker, et al.
Cancer Research|October 30, 2016
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2020
Histotype-specific analysis of acid ceramidase expression in ovarian cancerAhmed El-Balat, Thomas Karn, Uwe Holtrich, et al.
Breast Cancer Research : BCR|October 8, 2011
A clinically relevant gene signature in triple negative and basal-like breast cancerAchim Rody, Thomas Karn, Cornelia Liedtke, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|December 18, 2012
Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypesLars C Hanker, Achim Rody, Uwe Holtrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast CancerMaurizio Callari, Vera Cappelletti, Francesca D'Aiuto, et al.
Science Advances|September 16, 2020
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosisNandini Verma, Yaron Vinik, Ashish Saroha, et al.
Molecular Oncology|May 3, 2014
OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancerNicole Sänger, Eugen Ruckhäberle, Giampaolo Bianchini, et al.
Breast Cancer Research : BCR|March 11, 2009
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancersAchim Rody, Uwe Holtrich, Laos Pusztai, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2013
Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancerEugen Ruckhäberle, Thomas Karn, Carsten Denkert, et al.
Breast Care (Basel, Switzerland)|May 24, 2012
Breast Cancer Proteomics - Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag TechnologyEugen Ruckhäberle, Thomas Karn, Lars Hanker, et al.
Cancer Research|October 30, 2016
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2020
Histotype-specific analysis of acid ceramidase expression in ovarian cancerAhmed El-Balat, Thomas Karn, Uwe Holtrich, et al.
Breast Cancer Research : BCR|October 8, 2011
A clinically relevant gene signature in triple negative and basal-like breast cancerAchim Rody, Thomas Karn, Cornelia Liedtke, et al.
Pageof 11